Confirmation of EP300 gene mutations as a rare cause of Rubinstein–Taybi syndrome

CBP/p300 in cell growth, transformation, and development

Richard H. Goodman, Sarah M. Smolik · Genes & Development · 2000 · 1.8K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +10

Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP

Fred Petrif, Rachel H. Giles, Hans G. Dauwerse et al. · Nature · 1995 · 1.2K citations

Life Sciences, Genetics, Molecular Genetics +5

Gene Dosage–Dependent Embryonic Development and Proliferation Defects in Mice Lacking the Transcriptional Integrator p300

Tso-Pang Yao, S. Paul Oh, Miriam Fuchs et al. · Cell · 1998 · 1K citations · Full text

Life Sciences, Developmental Biology, Genetics +9

Genetic Heterogeneity in Rubinstein-Taybi Syndrome: Mutations in Both the CBP and EP300 Genes Cause Disease

Jeroen Roelfsema, Stefan J. White, Yavuz Ariyürek et al. · The American Journal of Human Genetics · 2005 · 478 citations · Full text

Life Sciences, Genetics, Molecular Genetics +6

Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation

Hiroaki Kawasaki, Richard Eckner, Tso‐Pang Yao et al. · Nature · 1998 · 332 citations

Life Sciences, Cell Biology, Molecular Biology +16